Cell Therapeutics Inc (CTIC): Is Cell Therapeutics Turning Over A New Leaf In ... Seeking Alpha The company is currently accruing patients into this study, which will compare Pixantrone and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL. The market size in the E.U. alone for the current indication is about 21,000 ... Active Buzzers: Cell Therapeutics Inc (NASDAQ:CTIC), Sarepta Therapeutics Inc ... |
